| [1] |
张彤彤. 骨髓增生异常综合征新分子遗传学标志的发现及临床应用研究[D]. 苏州: 苏州大学, 2018.
|
| [2] |
ARBER D A, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20):2391-2405.
DOI
PMID
|
| [3] |
USTUN C, AROCK M, KLUIN-NELEMANS H C, et al. Advanced systemic mastocytosis:from molecular and genetic progress to clinical practice[J]. Haematologica, 2016, 101(10):1133-1143.
|
| [4] |
MELCHERT M, KALE V, LIST A. The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes[J]. Curr Opin Hematol, 2007, 14(2):123-129.
PMID
|
| [5] |
VAN DEN BERGHE H, MICHAUX L. 5q-,twenty-five years later:a synopsis[J]. Cancer Genet Cytogenet, 1997, 94(1):1-7.
|
